CytomX Therapeutics (CTMX) Share-based Compensation (2014 - 2026)
CytomX Therapeutics (CTMX) posted Share-based Compensation of $2.58 million for Q2 2026, up 80.1% from $1.43 million a year earlier but down 45.2% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Share-based Compensation (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at CytomX Therapeutics was $10.15 million, up 38.6% year-over-year; for FY2025, it came in at $6.3 million, down 17.8% from FY2024.
- Annual Share-based Compensation has declined for six consecutive years, with a five-year compound annual growth rate of -15.7% (FY2020 to FY2025).
- In prior years, CytomX Therapeutics' Share-based Compensation was $7.67 million in FY2024 (-10.4%), $8.56 million in FY2023 (-34.8%), $13.13 million in FY2022 (-0.3%) and $13.17 million in FY2021 (-10.9%).
- Quarterly Share-based Compensation has run from a low of $1.23 million in Q3 2023 to a high of $4.71 million in Q1 2026 over five years.
- On a year-over-year basis, Share-based Compensation increased in four of the last eight quarters, with growth averaging 22.5%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q1 2026, with growth of 134.4%; the weakest was Q3 2023, with a decline of 54.5%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $4.71 million (Q1 2026), $1.48 million (Q4 2025) and $1.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | CytomX Therapeutics | 434.93 Mn | -727.09 Mn | - | 2.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.84 Mn |
| Jun 30, 2026 | 2.58 Mn |
| Mar 31, 2026 | 4.71 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 2.55 Mn |
| Sep 30, 2023 | 1.23 Mn |
| Jun 30, 2023 | 2.37 Mn |
| Mar 31, 2023 | 2.41 Mn |
| Dec 31, 2022 | 2.57 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 4.49 Mn |
| Mar 31, 2022 | 3.37 Mn |
| Dec 31, 2021 | 3.54 Mn |
API Access
CytomX Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();